Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1950 of 2026 entries
View as:

A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00413894 Org: User:
Start: 03/31/07 End: 10/31/08 Due: 10/31/09

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01007435 Org: User:
Start: 10/31/09 End: 01/28/14 Due: 01/28/15

Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03374137 Org: User:
Start: 03/09/18 End: 11/10/22 Due: 11/10/23

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Phase: N/A Priority: Normal
NCT ID: NCT02908685 Org: User:
Start: 10/19/16 End: 10/02/23 Due: 10/02/24

A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01159171 Org: User:
Start: 01/31/06 End: 07/31/10 Due: 07/31/11

Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).

Phase: N/A Priority: Normal
NCT ID: NCT03208933 Org: User:
Start: 10/23/17 End: 11/13/19 Due: 11/13/20

A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01483742 Org: User:
Start: 04/30/12 End: 09/30/13 Due: 09/30/14

A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01995383 Org: User:
Start: 11/30/13 End: 06/30/14 Due: 06/30/15

A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT00104143 Org: User:
Start: 10/31/07 End: - Due: -

A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT00616798 Org: User:
Start: 03/31/08 End: 02/28/10 Due: 02/28/11

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04709835 Org: User:
Start: 02/03/21 End: 10/13/21 Due: 10/13/22

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01399190 Org: User:
Start: 07/31/11 End: 02/28/14 Due: 02/28/15

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04222972 Org: User:
Start: 07/24/20 End: 01/27/25 Due: 01/27/26

A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Phase: N/A Priority: Normal
NCT ID: NCT01095835 Org: User:
Start: 02/28/05 End: 01/31/10 Due: 01/31/11

A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01948401 Org: User:
Start: 07/31/13 End: 04/30/14 Due: 04/30/15

A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002367 Org: User:
Start: - End: - Due: -

Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01579006 Org: User:
Start: 05/31/12 End: 03/31/14 Due: 03/31/15

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02553707 Org: User:
Start: 07/31/06 End: 12/31/08 Due: 12/31/09

An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01375478 Org: User:
Start: 04/30/11 End: 04/30/12 Due: 04/30/13

A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

Phase: N/A Priority: Normal
NCT ID: NCT01867125 Org: User:
Start: 07/31/13 End: 01/02/17 Due: 01/02/18

A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)

Phase: N/A Priority: Normal
NCT ID: NCT01120184 Org: User:
Start: 07/31/10 End: 09/16/16 Due: 09/16/17

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03493854 Org: User:
Start: 06/14/18 End: 06/02/23 Due: 06/02/24

Influenza Resistance Information Study

Phase: N/A Priority: Normal
NCT ID: NCT00884117 Org: User:
Start: 01/31/09 End: 11/30/15 Due: 11/30/16

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03708328 Org: User:
Start: 10/15/18 End: 07/09/24 Due: 07/09/25

An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT01716559 Org: User:
Start: 08/31/10 End: 03/31/12 Due: 03/31/13